Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men | Zendy

Sherry Y. Wu | Zendy; Fiona Yuen | Zendy; Ronald S. Swerdloff | Zendy; Youngju Pak | Zendy; Arthi Thirumalai | Zendy; Peter Y. Liu | Zendy; John K. Amory | Zendy; Feng Bai | Zendy; Laura Hull | Zendy; Diana Blithe | Zendy; Bradley D. Anawalt | Zendy; Toufan Parman | Zendy; Kyuri Kim | Zendy; Min S. Lee | Zendy; William J. Bremner | Zendy; Stephanie T. Page | Zendy; Christina Wang | Zendy

Open Access

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men

Author(s) -

Sherry Y. Wu,

Fiona Yuen,

Ronald S. Swerdloff,

Youngju Pak,

Arthi Thirumalai,

Peter Y. Liu,

John K. Amory,

Feng Bai,

Laura Hull,

Diana Blithe,

Bradley D. Anawalt,

Toufan Parman,

Kyuri Kim,

Min S. Lee,

William J. Bremner,

Stephanie T. Page,

Christina Wang

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-01528

Subject(s) - prodrug , pharmacokinetics , androgen , bioavailability , endocrinology , pharmacology , chemistry , medicine , hormone

11β-Methyl-19-nortestosterone-17β-dodecylcarbonate (11β-MNTDC) is an orally bioavailable prodrug of 11β-methyl-19-nortestosterone (11β-MNT) with androgenic and progestational activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore